Key Takeaways
- • CenterGate Capital, an Austin-based private equity firm managing over $750 million in assets, has invested in Canadian Dental Labs, a Toronto-based dental laboratory platform and manufacturer of dental prosthetics and orthodontic appliances.
- • Canadian Dental Labs operates 11 state-of-the-art laboratories across Canada through subsidiary brands including Shaw Lab Group (Ontario), Protec Dental (British Columbia), Hallmark Dental (Atlantic Canada), and Universal Dental (Alberta), serving over 5,000 independent dental professionals and dental service organizations.
- • The investment supports Canadian Dental Labs' growth strategy focused on scaling its national platform while investing in technology, people, and laboratory infrastructure; CEO Ali Rezaei will continue leading the company.
- • CenterGate's investment aligns with its core strategy of partnering with middle-market companies positioned for operational scaling and long-term growth initiatives within fragmented professional services markets.
- • Transaction advisors included Akerman and Blake, Cassels & Graydon (legal); BMO Middle Market M&A and ATB Cormark Capital Markets provided financial advisory services to Canadian Dental Labs.
Summary
CenterGate Capital announced a strategic investment in Canadian Dental Labs, marking the Austin-based private equity firm's entry into Canada's dental laboratory sector. The investment positions CenterGate to capitalize on consolidation trends within North America's fragmented dental services market, where independent laboratory operators and dental service organizations increasingly seek operational and capital support.
Canadian Dental Labs operates as a roll-up platform controlling 11 laboratories across major Canadian provinces. Its subsidiary network includes established regional players: Shaw Lab Group in Ontario, Protec Dental in British Columbia, Hallmark Dental in Atlantic Canada, and Universal Dental in Alberta. The platform serves a customer base exceeding 5,000 independent dental professionals and dental service organizations, generating scale while maintaining localized service relationships and craftsmanship capabilities. The company manufactures fixed and removable prosthetics as well as orthodontic appliances customized to individual patient specifications.
CenterGate's investment thesis reflects a disciplined approach to middle-market acquisition strategy. The firm, which manages more than $750 million in assets, targets companies with demonstrated market positions, operational complexity, and clear pathways to growth through technology investment, talent development, and network expansion. Canadian Dental Labs' existing management team, led by CEO Ali Rezaei, remains in place to execute growth objectives, suggesting CenterGate views the current leadership as a retained strength rather than a replacement scenario.
The transaction structure involved prominent North American advisors: Akerman and Blake, Cassels & Graydon provided legal counsel to CenterGate, while BMO Middle Market M&A and ATB Cormark Capital Markets advised Canadian Dental Labs on financial matters. This advisor selection underscores the deal's mid-market scale and cross-border complexity, typical of U.S.-Canada private equity transactions in professional services sectors.
The investment occurs within a broader consolidation wave affecting North American dental services. Private equity affiliation with dental practices has intensified significantly over the past decade, with PE-backed dental operators expanding both horizontally through acquisition and vertically through laboratory network integration. CenterGate's partnership with Canadian Dental Labs positions the firm to build operational leverage across Canada's laboratory sector while maintaining the local expertise and customer relationships that define value in dental manufacturing.
Canadian Dental Labs operates as a roll-up platform controlling 11 laboratories across major Canadian provinces. Its subsidiary network includes established regional players: Shaw Lab Group in Ontario, Protec Dental in British Columbia, Hallmark Dental in Atlantic Canada, and Universal Dental in Alberta. The platform serves a customer base exceeding 5,000 independent dental professionals and dental service organizations, generating scale while maintaining localized service relationships and craftsmanship capabilities. The company manufactures fixed and removable prosthetics as well as orthodontic appliances customized to individual patient specifications.
CenterGate's investment thesis reflects a disciplined approach to middle-market acquisition strategy. The firm, which manages more than $750 million in assets, targets companies with demonstrated market positions, operational complexity, and clear pathways to growth through technology investment, talent development, and network expansion. Canadian Dental Labs' existing management team, led by CEO Ali Rezaei, remains in place to execute growth objectives, suggesting CenterGate views the current leadership as a retained strength rather than a replacement scenario.
The transaction structure involved prominent North American advisors: Akerman and Blake, Cassels & Graydon provided legal counsel to CenterGate, while BMO Middle Market M&A and ATB Cormark Capital Markets advised Canadian Dental Labs on financial matters. This advisor selection underscores the deal's mid-market scale and cross-border complexity, typical of U.S.-Canada private equity transactions in professional services sectors.
The investment occurs within a broader consolidation wave affecting North American dental services. Private equity affiliation with dental practices has intensified significantly over the past decade, with PE-backed dental operators expanding both horizontally through acquisition and vertically through laboratory network integration. CenterGate's partnership with Canadian Dental Labs positions the firm to build operational leverage across Canada's laboratory sector while maintaining the local expertise and customer relationships that define value in dental manufacturing.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.